AP-101 is a Phase 3-ready recombinant human antibody designed to selectively deplete toxic, misfolded forms of superoxide dismutase 1 (SOD1) while preserving the normal, protective function of healthy SOD1. AP-101 aims to slow the spread of SOD1 pathology and support the body’s natural clearance of harmful proteins.